Clinical Trial Update: ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase feasibility trial evaluating indocyanine green–enabled mapping of ovarian sentinel lymph nodes in ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Ovarian Cancer, Adnexal Mass | EARLY_Phase 1 | Status: COMPLETED